A center focused on understanding rare genetic diseases through advanced genomic techniques.
Baylor College of Medicine - Mendelian Genomics Research Center (BCM-MGRC)
This study at Baylor College of Medicine is working to help people with rare genetic diseases get better diagnoses by using advanced technology to find the genetic causes of these conditions, so patients can have more options for understanding and treating their health issues.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11099775 on NIH RePORTER |
What this research studies
The Baylor College of Medicine Mendelian Genomics Research Center (BCM-MGRC) aims to improve the diagnosis of rare genetic diseases that are often difficult to identify through standard clinical methods. By leveraging a diverse cohort of around 15,000 individuals and families, the center will utilize cutting-edge genomic sequencing technologies and data analysis methods to uncover the genetic causes of these conditions. Patients will benefit from a collaborative approach that integrates data sharing and advanced research techniques to enhance understanding and treatment options for rare diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals and families with challenging-to-diagnose rare diseases that have not been resolved through routine clinical studies.
Not a fit: Patients with common genetic conditions or those whose diseases have already been diagnosed through standard methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better treatment options for patients with rare genetic conditions.
How similar studies have performed: Previous research in the field of Mendelian genomics has shown promise in improving diagnostic accuracy and understanding of rare diseases, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Gibbs, Richard a — Baylor College of Medicine
- Study coordinator: Gibbs, Richard a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.